Results 221 to 230 of about 77,038 (354)
Microneedle Assisted Melittin-Chondroitin Sulfate Administration for the Transdermal Therapy of Rheumatoid Arthritis. [PDF]
Jin L +6 more
europepmc +1 more source
Secretion of chondroitin sulfate from embryonic epidermal cells in Xenopus laevis. [PDF]
Sumio Nishikawa, F Sasaki
openalex +1 more source
Cancer Neuroscience: Decoding Neural Circuitry in Tumor Evolution for Targeted Therapy
This review highlights the pivotal role of the nervous system in cancer progression, emphasizing how neural–tumor interactions—via synaptic signaling, neurotransmitters, and paracrine factors—reshape the tumor microenvironment. It introduces cancer neuroscience as an emerging field and proposes integrating advanced tools such as AI and optogenetics to ...
Mengyu Yuan +4 more
wiley +1 more source
Albumin Nanocages with Methotrexate and Chondroitin Sulfate as a Dual pH/GSH-Responsive Tumor Targeting Nanomedicine for Synergistic Cancer Therapy. [PDF]
Iqbal H +10 more
europepmc +1 more source
Extracellular vesicles (EVs) are promising biomarkers, but their heterogeneity limits clinical use. A novel high‐affinity phosphatidylserine (PS)‐binding reagent is introduced that reveals ≈90% of circulating EVs are PS⁺. This enables in vivo tracking, showing rapid EV clearance and retention in spleen immune cells—advancing EV quantification ...
Lavinia Flaskamp +9 more
wiley +1 more source
Modulation of electrical activity of proteinoid microspheres with chondroitin sulfate clusters. [PDF]
Mougkogiannis P, Adamatzky A.
europepmc +1 more source
Biocompatible Mesoporous Materials for Bone Therapy
Biocompatible mesoporous materials (BMMs), characterized by high specific surface area, tunable pore size, different shapes and structures, and multidimensional functionalized modifications, have revolutionary applications in treating bone‐related diseases.
Biao Yu +6 more
wiley +1 more source
Engineering of lipid membranes asymmetrically functionalized with chondroitin sulfate.
Rodríguez-García T +8 more
europepmc +1 more source

